Cargando…

WCN23-0787 A CASE OF IGA VASCULITIS THAT DEVELOPED GROSS HEMATURIA AND LOWER-LIMB PURPURA FOLLOWING COVID-19 VACCINES

Detalles Bibliográficos
Autores principales:	MORI, K., Yamada, K., Aoki, R., Saeki, H., Kobayashi, T., Maiguma, M., Kihara, M., Ueda, S., Gohda, T., Suzuki, Y.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Published by Elsevier Inc. 2023
Materias:	Covid-19 and CKD
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10025595/ http://dx.doi.org/10.1016/j.ekir.2023.02.1011

Ejemplares similares

WCN23-1022 Persistent microscopic hematuria in IgA nephropathy and frequency of gross hematuria following SARS-CoV-2 mRNA vaccination
por: YOKOTE, S., et al.
Publicado: (2023)

WCN23-0981 RISK FACTORS FOR COVID-19 MORTALITY IN HEMODIALYSIS PATIENTS
por: TOMANOSKI, V., et al.
Publicado: (2023)

WCN23-0825 TELENEPHROLOGY: MANAGING CHRONIC KIDNEY DISEASE DURING COVID-19 PANDEMIC
por: Sharma, S.K., et al.
Publicado: (2023)

WCN23-0430 PREDICTORS FOR FAILURE REDUCTION OF HEMODIALYSIS FREQUENCY DURING THE PANDEMIC
por: Pattharanitima, P., et al.
Publicado: (2023)

WCN23-0345 EFFECTIVENESS OF COVID-19 VACCINE IN PATIENT UNDERGOING HEMODIALYSIS
por: FATIMAH, S., et al.
Publicado: (2023)

WCN23-0616 SARS-COV-2 INFECTION AMONG HOSPITALIZED PATIENTS WITH CHRONIC KIDNEY DISEASE
por: Munaa, B., et al.
Publicado: (2023)

WCN23-1183 DISPARITIES IN CHRONIC KIDNEY DISEASE RISKS: DATA FROM THE CURE-CKD COVID-19 REGISTRY
por: Nicholas, S., et al.
Publicado: (2023)

WCN23-0651 LONG-TERM EFFECTIVENESS OF COVID-19 VACCINE AMONG DIALYSIS PATIENTS
por: Rosa Diez, G., et al.
Publicado: (2023)

WCN23-1238 COMORBIDITIES ASSOCIATED WITH INCREASED RISK OF DEATH IN CKD PATIENTS WITH COVID-19
por: BRAZ, B., et al.
Publicado: (2023)

WCN23-0938 IMPACT OF THE COVID-19 PANDEMIC IN PATIENTS ATTENDING RENAL CLINIC AT KINGSTON PUBLIC HOSPITAL, JAMAICA
por: DEWAR, D., et al.
Publicado: (2023)

WCN23-0519 VACCINE RESPONSE AGAINST SARS-Cov-2 AMONG HEMODIALYSIS PATIENTS IN TWO SENEGALESE CENTERS IN 2021
por: MOTOULA LATOU, L.N.P., et al.
Publicado: (2023)

WCN23-0089 SERUM INDOXYL SULFATE IS ASSOCIATED WITH COVID-19 INFECTION AND DISEASE SEVERITY IN HEMODIALYSIS PATIENTS
por: Stepanova MD, N., et al.
Publicado: (2023)

WCN23-0389 ASSOCIATED FACTORS TO CLINICAL OUTCOMES OF COVID-19 AMONG HOSPITALIZED PATIENTS UNDERGOING MAINTENANCE DIALYSIS
por: MEDRIANO, R., et al.
Publicado: (2023)

WCN23-0655 INCIDENCE AND OUTCOMES OF COVID-19 IN DIALYSIS PATIENTS. DATA FROM THE ARGENTINE REGISTRY OF CHRONIC DIALYSIS
por: Bisigniano, L., et al.
Publicado: (2023)

WCN23-1086 ACUTE KIDNEY INJURY AFTER COVID 19 INFECTION IN CHRONIC KIDNEY DISEASE PATIENTS OF BANGLADESH: RETROSPECTIVE STUDY
por: NOBI, F., et al.
Publicado: (2023)

WCN23-0120 MEDIUM AND LONG TERM ANTIBODY RESPONSE TO COVID-19 VACCINATION IN PATIENTS RECEIVING HEMODIALYSIS (HD) - A CROSS SECTIONAL STUDY
por: Cheema, S., et al.
Publicado: (2023)

WCN23-1019 CUMULATIVE INCIDENCE OF COVID-19 AND VACCINE PROFILES AMONG ASEAN PERITONEAL DIALYSIS POPULATIONS: A PRELIMINARY RESULT OF THE "InCoV-PD" STUDY GROUP
por: Mushahar, L., et al.
Publicado: (2023)

WCN23-0291 USE OF ANGIOTENSIN-CONVERTING ENZYME INHIBITORS (ACEIs) AND ANGIOTENSIN-RECEPTOR BLOCKERS (ARBs) AND INCIDENCE OF PNEUMONIA OR INFLUENZA OR COVID-19: A SYSTEMATIC REVIEW AND META-ANALYSIS
por: Qin, X., et al.
Publicado: (2023)

WCN23-0886 CONTRIBUTION TO THE STUDY OF ADVERSE EVENTS FOLLOWING VACCINATION AGAINST COVID-19 IN CHRONIC HEMODIALYSIS PATIENTS IN SENEGAL: A REVIEW OF 367 CASES
por: SARR, I., et al.
Publicado: (2023)

WCN23-0544 CLINICAL PROFILE, IMMUNOSUPPRESSIVE MANAGMENT AND OUTCOME IN ADULT RENAL ALLOGRAFT RECIPIENTS WITH COVID-19 INFECTION: A CASE SERIES FROM SINGLE CENTRE IN BANGLADESH
por: MAHJABIN, S., et al.
Publicado: (2023)

WCN23-0166 NEW ONSET RENAL REPLACEMENT THERAPY IS A PREDICTOR OF COVID-19 ADVERSE OUTCOME IN PATIENTS WITH ADVANCED CHRONIC KIDNEY DISEASE DUE TO TYPE 2 DIABETES MELLITUS
por: KLOCHKOVA, N., et al.
Publicado: (2023)

WCN23-0583 GROSS HEMATURIA AFTER COVID-19 mRNA VACCINATION: A PROSPECTIVE COHORT STUDY
por: AOKI, R., et al.
Publicado: (2023)

WCN23-1093 First report of durability of antibody response in maintenance haemodialysis patients and kidney transplant recipients vaccinated with ChAdOx1 nCoV-19 vaccine: A prospective, multicentre, observational, study
por: CHAUHAN, S.
Publicado: (2023)

WCN23-0624 ACUTE KIDNEY INJURY AND COVID-19
por: JERNDAL, H., et al.
Publicado: (2023)

WCN23-0316 COVID-19 VACCINATION INDUCED MINIMAL CHANGED DISEASE
por: ALKANDARI, N., et al.
Publicado: (2023)

WCN23-0333 THE FREQUENCY OF DYSNATREMIA IN PATIENTS ADMITTED WITH COVID-19 INFECTION
por: KHAN, F.G., et al.
Publicado: (2023)

WCN23-0317 AKI IN HOSPITALIZED COVID-19 PATIENTS- AN EPIDEMIOLOGY STUDY IN A TERTIARY CENTER
por: OOI, S., et al.
Publicado: (2023)

WCN23-1131 RISK OF AKI IN COVID-19 PATIENTS: CLINICAL COURSE AND OUTCOMES
por: Flores Fonseca MD, M.M., et al.
Publicado: (2023)

WCN23-0359 RENAL FLARE IN ADOLESCENTS WITH LUPUS NEPHRITIS RECEIVED COVID-19 mRNA VACCINE
por: THEPVEERA, S., et al.
Publicado: (2023)

WCN23-0208 THE PREVALENCE AND SHORT-TERM OUTCOMES OF ACUTE KIDNEY INJURY IN PATIENTS HOSPITALIZED WITH COVID-19 INFECTION
por: OGANGA, M., et al.
Publicado: (2023)

WCN23-1216 KIDNEY BIOPSIES DURING THE COVID-19 OUTBREAK: A SERIES OF CASES
por: Pantaleon, H., et al.
Publicado: (2023)

WCN23-0637 CLINICAL PROFILE AND OUTCOMES OF COVID-19 IN RENAL TRANSPLANT RECIPIENTS – A SINGLE CENTRE EXPERIENCE
por: ANAGHASHREE, U., et al.
Publicado: (2023)

WCN23-0213 PROXIMAL TUBULAR DYSFUNCTION AS A PREDICTOR OF AKI IN HOSPITALIZED COVID-19 PATIENTS
por: ALIMUL BARI, A., et al.
Publicado: (2023)

WCN23-0071 CYTOKINE ADSORBING COLUMN IN SEVERE COVID-19 PATIENTS WITH ACUTE KIDNEY INJURY
por: Madhyastha, P., et al.
Publicado: (2023)

WCN23-0857 Utility of urinary biomarkers for diagnosis of acute kidney injury (AKI) in COVID-19
por: SAMRA, T., et al.
Publicado: (2023)

IgA Nephropathy with Gross Hematuria Following COVID-19 mRNA Vaccination
por: Nihei, Yoshihito, et al.
Publicado: (2022)

WCN23-1046 PATHOGENETIC ASPECTS OF THE DEVELOPMENT OF ACUTE KIDNEY INJURY IN COVID 19: OWN OBSERVATION DATA
por: GARAZHAYEVA, L., et al.
Publicado: (2023)

WCN23-0357 Quercetin potentially suppresses renal fibrosis in patients with COVID-19 under hypoxic state
por: GUO, J., et al.
Publicado: (2023)

WCN23-0230 Life Threatening Spontaneous Hematoma in Unusual sites in patient with Covid-19 on Anticoagulant Therapy (4 case reports)
por: SAMAD, M., et al.
Publicado: (2023)

WCN23-1032 CHARACTERISTICS OF ACUTE KIDNEY INJURY IN COVID-19 ADULT PATIENTS IN A SINGLE CENTER IN INDONESIA
por: Muzasti, R., et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_k8f68co5bqqblvvj0mrfij2dsu